首页> 外文期刊>Experimental and clinical transplantation >De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years
【24h】

De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years

机译:肾移植受者的新内脏恶性肿瘤:2054名受者的单中心经验超过30年

获取原文
           

摘要

Objectives: We report the incidence and pattern of malignancies in renal transplant recipients from our department. Materials and Methods: Between March 1983 and August 2013, the records of 2054 renal transplant recipients from our department were retrospectively reviewed with regard to type of neoplasm, age, gender, interval between the transplant and the diagnosis of malignancy, immunosuppressive regimens, graft functional status, and rejection episodes. Results: Among the 2054 renal transplant recipients, visceral malignancies developed in 74 patients (3.6%). The mean age at transplant was 43.9 years, and the mean age at death was 61.9 years. Sixty eight patients (91.9%) died with a functioning graft. Fifty-four (73%) died during follow-up. The mean time from transplant to malignancy was 96.4 months, and from malignancy to death was 27.5 months. No difference regarding the type of immunosuppression, the type of donor, or the interval between transplant and malignancy was detected when we compared cancers. Conclusions: Malignancies after a renal transplant display aggressive behavior and occur more frequently several years after the transplant, but they also may occur earlier. The type of immuno-suppression, the type of donor, or the interval between transplant and malignancy do not differ significantly among cancers.
机译:目的:我们报告了我科肾移植受者恶性肿瘤的发生率和类型。资料与方法:回顾性分析1983年3月至2013年8月我科2054例肾移植受者的肿瘤种类,年龄,性别,移植间隔与恶性肿瘤的诊断,免疫抑制方案,移植物功能。状态和拒绝事件。结果:在2054例肾移植受者中,有74例(3.6%)出现内脏恶性肿瘤。移植的平均年龄为43.9岁,死亡的平均年龄为61.9岁。六十八名患者(91.9%)死于功能正常的移植物。随访期间有54人(73%)死亡。从移植到恶性肿瘤的平均时间为96.4个月,从恶性肿瘤到死亡的平均时间为27.5个月。当我们比较癌症时,在免疫抑制类型,供体类型或移植与恶性肿瘤之间的间隔方面未发现差异。结论:肾移植后的恶性肿瘤表现出侵袭性行为,并在移植后数年内更频繁地发生,但也可能更早发生。免疫抑制的类型,供体的类型或移植与恶性肿瘤之间的间隔在癌症之间没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号